Ligand id: 9597

Name: remtolumab

Immunopharmacology Comments
Remtolumab neutralises the biological effects of IL-17A and TNF, which are two proinflammatory mediators of rheumatic diseases.
Immunopharmacology Disease
Disease X-Refs Comment References
Rheumatoid arthritis Disease Ontology: DOID:7148
OMIM: 180300
Phase 2 clinical candidate for RA- see NCT02433340
Psoriatic arthritis Disease Ontology: DOID:9008
Phase 2 clinical candidate for PsA- see NCT02429895, which indicates that investigation in PsA has been terminated on business grounds.